Martin VanTrieste
President and Chief Executive Officer at Civica Rx
Under VanTrieste’s leadership, Civica has expanded its membership to include more than 55 health systems representing over 1,500 hospitals across the US, and has delivered nearly 60 essential medications for hospitals, 11 of which are being used to treat COVID-19 patients. Most recently, Civica announced its plans to manufacture and distribute insulin that, once approved, will be available to people with diabetes at significantly lower prices than insulin currently on the market. The availability of affordable insulin will benefit people with diabetes who have been forced to choose between life sustaining medicines and living expenses, particularly those uninsured or underinsured who often pay the most out of pocket for their medications.
